Abstract
OBJECTIVE: To assess the risks of short and long-term use of a recently launched OC with a 24-day drospirenone regimen (DRSP24d) and to compare it to the risks of established OCs in a study population that is representative of the actual users of the individual preparations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
